Generic weight-loss drug approval ‘really good news,’ but doctor warns of long-term consequences
April 30, 2026
April 30, 2026
MONTREAL – Health Canada’s approval of the generic version of semaglutide, commonly known as Ozempic, has been heralded as a sea change in improving accessibility to a life-changing drug.
Still, experts also warn this is no time to throw the door wide open to weight-loss drugs.
“The approval is really good news. It increases equity which is important,” said Dr. Kaberi Dasgupta, a professor of medicine at McGill University. “People need treatments for excess weight and a lot of medical conditions associated with obesity. So, these semaglutides are incredible tools.”
But she also says their effectiveness and increasing availability pose several questions.
“The negative side is that it might become a bit too easy to not try to make our environments healthier,” she said.
Read more: https://www.ctvnews.ca/health/article/how-generic-versions-of-ozempic-could-shape-canada/
Mainstream NewsBed Bug Infestation Forces Closure of Fort Simpson Schools
Two schools in Fort Simpson, N.W.T., will close starting Monday due to a bed bug infestation, with no confirmed reopening date.
Mainstream NewsThe Complex History of Bible Translations in Greenland and Labrador
Early Christian missionaries in Greenland and Labrador relied on Inuit converts to translate the Bible, revealing a complex interplay of cultural exchange and religious adaptation.
Mainstream NewsInuit-Led Pirutsiagutiit Program Replaces Child First Initiative
Federal government transfers $575M in child health and social support funding to Inuit organizations, ending uncertainty over previous program.
Mainstream NewsWhitehorse Students Engage With Canadian Astronauts Aboard the ISS
Students from Whitehorse schools connected with Canadian astronauts Jenni Gibbons and Joshua Kutryk, gaining insights into space exploration and inspiring future careers in science.